Compare STIM & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STIM | ICG |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.5M | 97.1M |
| IPO Year | 2018 | 2023 |
| Metric | STIM | ICG |
|---|---|---|
| Price | $2.09 | $1.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.00 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 1.4M | 88.5K |
| Earning Date | 11-04-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.43 |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $129,873,000.00 | $36,367,850.00 |
| Revenue This Year | $101.67 | N/A |
| Revenue Next Year | $10.87 | $75.98 |
| P/E Ratio | ★ N/A | $8.40 |
| Revenue Growth | ★ 78.61 | 6.53 |
| 52 Week Low | $1.25 | $0.93 |
| 52 Week High | $5.92 | $4.66 |
| Indicator | STIM | ICG |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 52.77 |
| Support Level | $1.34 | $1.75 |
| Resistance Level | $1.50 | $1.86 |
| Average True Range (ATR) | 0.16 | 0.16 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 94.80 | 35.42 |
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.